TY - JOUR
T1 - The Role of Hepatic Fat Accumulation in Glucose and Insulin Homeostasis-Dysregulation by the Liver
AU - London, Amalie
AU - Lundsgaard, Anne-Marie
AU - Kiens, Bente
AU - Bojsen-Møller, Kirstine Nyvold
PY - 2021/1/20
Y1 - 2021/1/20
N2 - Accumulation of hepatic triacylglycerol (TG) is associated with obesity and metabolic syndrome, which are important pathogenic factors in the development of type 2 diabetes. In this narrative review, we summarize the effects of hepatic TG accumulation on hepatic glucose and insulin metabolism and the underlying molecular regulation in order to highlight the importance of hepatic TG accumulation for whole-body glucose metabolism. We find that liver fat accumulation is closely linked to impaired insulin-mediated suppression of hepatic glucose production and reduced hepatic insulin clearance. The resulting systemic hyperinsulinemia has a major impact on whole-body glucose metabolism and may be an important pathogenic step in the development of type 2 diabetes.
AB - Accumulation of hepatic triacylglycerol (TG) is associated with obesity and metabolic syndrome, which are important pathogenic factors in the development of type 2 diabetes. In this narrative review, we summarize the effects of hepatic TG accumulation on hepatic glucose and insulin metabolism and the underlying molecular regulation in order to highlight the importance of hepatic TG accumulation for whole-body glucose metabolism. We find that liver fat accumulation is closely linked to impaired insulin-mediated suppression of hepatic glucose production and reduced hepatic insulin clearance. The resulting systemic hyperinsulinemia has a major impact on whole-body glucose metabolism and may be an important pathogenic step in the development of type 2 diabetes.
KW - glucose metabolism
KW - hepatic glucose production
KW - hyperinsulinemic-euglycemic clamp
KW - insulin clearance
KW - insulin resistance
KW - molecular regulation
KW - non-alcoholic fatty liver disease (NAFLD)
KW - proton MR spectroscopy
KW - Insulin clearance
KW - Hyperinsulinemic‐euglycemic clamp
KW - Hepatic glucose production
KW - Proton MR spectroscopy
KW - Non‐alcoholic fatty liver disease (NAFLD)
KW - Molecular regulation
KW - Glucose metabolism
KW - Insulin resistance
UR - http://www.scopus.com/inward/record.url?scp=85114065491&partnerID=8YFLogxK
U2 - 10.3390/jcm10030390
DO - 10.3390/jcm10030390
M3 - Review
C2 - 33498493
SN - 2077-0383
VL - 10
SP - 1
EP - 13
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
IS - 3
M1 - 390
ER -